Trabalho de Conclusão de Curso - Graduação

Avaliação dos níveis séricos de fósforo em pessoas vivendo com HIV/AIDS

Introduction: The insertion of antiretroviral therapy has significantly reduced the morbidity and mortality rates of people living with HIV/AIDS (PLWHA). However, several adverse events have been reported as a result of long-term exposure to ART, such as metabolic disorders. Objective: To anal...

ver descrição completa

Autor principal: OLIVA, Thirza Damasceno Ramos
Outros Autores: SILVA, Isabella Mesquita Sfair
Grau: Trabalho de Conclusão de Curso - Graduação
Publicado em: 2023
Assuntos:
HIV
ART
Acesso em linha: https://bdm.ufpa.br:8443/jspui/handle/prefix/6099
Resumo:
Introduction: The insertion of antiretroviral therapy has significantly reduced the morbidity and mortality rates of people living with HIV/AIDS (PLWHA). However, several adverse events have been reported as a result of long-term exposure to ART, such as metabolic disorders. Objective: To analyze serum phosphate levels in people living with HIV/AIDS on ART. Method: Observational, analytical, cross-sectional study, classified as to the purpose as applied research. The procedures adopted were field research and documental research. Results: In the series of 106 patients, 30 (28.3%) were hypophosphatemic and 76 (71.7%) were normophosphatemic. There was a statistically significant direct relationship between years of infection (P=< 0.001) and years of ART use (P=< 0.001), and serum phosphorus levels. As for the clinical aspects related to hypophosphatemia, only paresthesia showed a statistically significant relationship (p = 0.016). No statistically significant relationship was found between serum phosphorus levels and glomerular filtration rate, serum levels of TCD4+ lymphocytes, and bone mineral density (p>0.05). The use of TDF in an ART regimen was statistically significant (p=0.0001). From the analysis of ART regimens that contained TDF and serum phosphorus levels, it was inferred that no specific regimen causes hypophosphatemia (p>0.05), but only TDF alone. The use of nephroprotection did not represent statistical significance when compared to serum phosphorus levels in hypophosphatemic patients (p>0.05). Older individuals use less Tenofovir compared to the younger population, but have higher levels of hypophosphatemia when using the drug. Time of infection and the use of TDF, as well as the time of ART and the use of TDF, are responsible for 41.2% of hypophosphatemia cases. Conclusion: The prevalence of hypophosphatemia in the series studied was 28.3%. There was statistical relevance between the reduced levels of phosphorus and the variables time of HIV infection, duration of ART use, paresthesia and use of TDF in an ART regimen.